114 related articles for article (PubMed ID: 11597405)
1. 3-D-QSAR/CoMFA and recognition models of benzimidazole derivatives at the 5-HT(4) receptor.
López-Rodríguez ML; Murcia M; Benhamú B; Viso A; Campillo M; Pardo L
Bioorg Med Chem Lett; 2001 Nov; 11(21):2807-11. PubMed ID: 11597405
[TBL] [Abstract][Full Text] [Related]
2. Benzimidazole derivatives. 3. 3D-QSAR/CoMFA model and computational simulation for the recognition of 5-HT(4) receptor antagonists.
López-Rodríguez ML; Murcia M; Benhamú B; Viso A; Campillo M; Pardo L
J Med Chem; 2002 Oct; 45(22):4806-15. PubMed ID: 12383006
[TBL] [Abstract][Full Text] [Related]
3. 5-HT(4) receptor antagonists: structure-affinity relationships and ligand-receptor interactions.
López-Rodriguez ML; Benhamú B; Morcillo MJ; Murcia M; Viso A; Campillo M; Pardob L
Curr Top Med Chem; 2002 Jun; 2(6):625-41. PubMed ID: 12052197
[TBL] [Abstract][Full Text] [Related]
4. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
[TBL] [Abstract][Full Text] [Related]
5. Benzimidazole derivatives. Part 1: Synthesis and structure-activity relationships of new benzimidazole-4-carboxamides and carboxylates as potent and selective 5-HT4 receptor antagonists.
López-Rodríguez ML; Benhamú B; Viso A; Morcillo MJ; Murcia M; Orensanz L; Alfaro MJ; Martín MI
Bioorg Med Chem; 1999 Nov; 7(11):2271-81. PubMed ID: 10632037
[TBL] [Abstract][Full Text] [Related]
6. Benzimidazole derivatives. 2. Synthesis and structure-activity relationships of new azabicyclic benzimidazole-4-carboxylic acid derivatives with affinity for serotoninergic 5-HT(3) receptors.
López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada ID; Orensanz L; Alfaro MJ; Martín MI
J Med Chem; 1999 Dec; 42(24):5020-8. PubMed ID: 10585211
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation and binding mode modeling of benzimidazole derivatives targeting the cannabinoid receptor type 1.
Espinosa-Bustos C; Lagos CF; Romero-Parra J; Zárate AM; Mella-Raipán J; Pessoa-Mahana H; Recabarren-Gajardo G; Iturriaga-Vásquez P; Tapia RA; Pessoa-Mahana CD
Arch Pharm (Weinheim); 2015 Feb; 348(2):81-8. PubMed ID: 25641513
[TBL] [Abstract][Full Text] [Related]
8. New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
Brea J; Rodrigo J; Carrieri A; Sanz F; Cadavid MI; Enguix MJ; Villazón M; Mengod G; Caro Y; Masaguer CF; Raviña E; Centeno NB; Carotti A; Loza MI
J Med Chem; 2002 Jan; 45(1):54-71. PubMed ID: 11754579
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and binding properties of novel and selective 5-HT(3) and 5-HT(4) receptor ligands.
Modica M; Santagati M; Guccione S; Russo F; Cagnotto A; Goegan M; Mennini T
Eur J Med Chem; 2000 Dec; 35(12):1065-79. PubMed ID: 11248405
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands.
López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada I; Avila D; Marco I; Schiapparelli L; Frechilla D; Del Río J
Bioorg Med Chem Lett; 2003 Oct; 13(19):3177-80. PubMed ID: 12951088
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
Vyas VK; Gupta N; Ghate M; Patel S
SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.
Pauli I; Ferreira LG; de Souza ML; Oliva G; Ferreira RS; Dessoy MA; Slafer BW; Dias LC; Andricopulo AD
Future Med Chem; 2017 May; 9(7):641-657. PubMed ID: 28509592
[TBL] [Abstract][Full Text] [Related]
14. Benzimidazole derivatives. 4. The recognition of the voluminous substituent attached to the basic amino group of 5-HT4 receptor antagonists.
López-Rodríguez ML; Benhamú B; Murcia M; Alvaro E; Campillo M; Pardo L
J Comput Aided Mol Des; 2003 Aug; 17(8):515-24. PubMed ID: 14703122
[TBL] [Abstract][Full Text] [Related]
15. Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation.
de la Fuente T; Martín-Fontecha M; Sallander J; Benhamú B; Campillo M; Medina RA; Pellissier LP; Claeysen S; Dumuis A; Pardo L; López-Rodríguez ML
J Med Chem; 2010 Feb; 53(3):1357-69. PubMed ID: 20078106
[TBL] [Abstract][Full Text] [Related]
16. Combined CoMFA and CoMSIA 3D-QSAR study of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
Romero-Parra J; Chung H; Tapia RA; Faúndez M; Morales-Verdejo C; Lorca M; Lagos CF; Di Marzo V; David Pessoa-Mahana C; Mella J
Eur J Pharm Sci; 2017 Apr; 101():1-10. PubMed ID: 28137469
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the structure requirement for 5-HT₆ binding affinity of arylsulfonyl derivatives: a computational study.
Hao M; Li Y; Li H; Zhang S
Int J Mol Sci; 2011; 12(8):5011-30. PubMed ID: 21954341
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
Sindhu T; Srinivasan P
J Recept Signal Transduct Res; 2014 Aug; 34(4):241-53. PubMed ID: 25072161
[TBL] [Abstract][Full Text] [Related]
19. Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands.
López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada I; Avila D; Marco I; Schiapparelli L; Frechilla D; Del Río J
Bioorg Med Chem; 2004 Oct; 12(19):5181-91. PubMed ID: 15351401
[TBL] [Abstract][Full Text] [Related]
20. Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists.
Candura SM; Messori E; Franceschetti GP; D'Agostino G; Vicini D; Tagliani M; Tonini M
Br J Pharmacol; 1996 Aug; 118(8):1965-70. PubMed ID: 8864530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
